Glucocorticoid-Induced Increase in Lymphocytic FKBP51 Messenger Ribonucleic Acid Expression: A Potential Marker for Glucocorticoid Sensitivity, Potency, and Bioavailability
The DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.
Abstract
To reduce the side effects of corticosteroid treatment, the administered dose of glucocorticoids (GCs) should be kept to a minimum while preserving therapeutically needed intracellular levels. Currently available assays to determine individual sensitivity to GCs are either imprecise or based on inhibition by GCs of lymphocyte proliferation following stimulation with phytohemagglutinin or other mitogens, which may influence the GC signal transduction pathway. Using the human lymphoblastoid cell line IM-9 as a model system, we studied whether the GC-induced increase of the mRNA encoding the 51-kDa FK506-binding protein (FKBP51) could be used for the development of a novel assay, ultimately to be used in native human peripheral blood mononuclear cells (PBMCs). GC addition to IM-9 cells resulted in a dose-dependent increase of FKBP51 mRNA levels within 2 h, followed by a further increase until 24 h. Northern blot analysis and real-time PCR yielded similar results. Coincubation of GCs with the GC receptor antagonist ORG 34116 or the protein synthesis inhibitor cycloheximide suggested a direct, GC receptor-mediated up-regulation of FKBP51 gene transcription. Expected differences in potency among different GCs could be readily demonstrated in this system. Extending our observations in IM-9 lymphoblasts to normal PBMCs, we found a dose-dependent increase of FKBP51 mRNA on ex vivo incubation of native human PBMCs with GCs, with a sensitivity of about 10(-9) M for dexamethasone. Moreover, dexamethasone ingestion increased FKBP51 mRNA in PBMCs in vivo, extending the use of this assay to the measurement of GC bioavailability. Finally, using this method we were able to demonstrate partial GC-insensitivity in a 6-month-old infant suffering from congenital adrenal hyperplasia caused by 21-hydroxylase deficiency. We conclude that the induction of FKBP51 mRNA by GCs may be a suitable marker to assess individual GC sensitivity, the in vitro measurement of GC potency, and the in vivo determination of GC bioavailability.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The expression of FKBP5 is induced by glucocorticoids, thus forming an ultrashort intracellular negative-feedback loop for GR activity in response to stressor exposure (Vermeer et al, 2003)”
From Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond (2017) · cites this paper as Vermeer et al, 2003
In the citing paper
“FKBP5 induction by GR activation has been proposed as a molecular indicator of GR sensitivity (Ja ¨a ¨skela ¨inen et al, 2011;Vermeer et al, 2003).”
From Dexamethasone stimulated gene expression in peripheral blood is a sensitive marker for glucocorticoid receptor resistance in depressed patients (2012) · cites this paper as Vermeer et al, 2003
In the citing paper
“FKBP5 is a heatshock protein 90 associated cochaperone of the GR and its expression is strongly induced by glucocorticoids via intronic steroid response elements as part of an intracellular short negative feedback loop for GR activity (Vermeer et al, 2003).”
From Dexamethasone stimulated gene expression in peripheral blood is a sensitive marker for glucocorticoid receptor resistance in depressed patients (2012) · cites this paper as Vermeer et al, 2003
Citations
Cites
Nuclear Receptor Coregulators: Cellular and Molecular Biology*
McKenna, N. J., Lanz, R. B., & O’Malley, B. W. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0366 · Cited by 1,911
Steroid Receptor Interactions with Heat Shock Protein and Immunophilin Chaperones*
Pratt, W. B., & Toft, D. O. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.3.0303 · Cited by 1,791
Hench, P. S., Kendall, E. C., Slocumb, C. H., & Polley, H. F. (1949) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00526-3 · Cited by 1,179
Quantification on the LightCycler
Rasmussen, R. (2001) · Rapid Cycle Real-Time PCR · doi:10.1007/978-3-642-59524-0_3 · Cited by 892 · cited 1×
“This number was used to relate the initial quantity of cDNA of interest in each sample to one another (21).”
MethodTranscriptional cross-talk, the second mode of steroid hormone receptor action
Göttlicher, M., Heck, S., & Herrlich, P. (1998) · Journal of Molecular Medicine · doi:10.1007/s001090050242 · Cited by 388
Mechanism of glucocorticoid receptor down-regulation by glucocorticoids.
Rosewicz, S., McDonald, A. R., Maddux, B. A., Goldfine, I. D., Miesfeld, R. L., & Logsdon, C. D. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)69104-5 · Cited by 322 · cited 1×
“On the other hand, it has been reported that GCs induce downregulation of GC receptor mRNA itself in IM-9 cells (41).”
BackgroundThe human beta 2-microglobulin gene. Primary structure and definition of the transcriptional unit.
Güssow, D., Rein, R., Ginjaar, I., Hochstenbach, F., Seemann, G., Kottman, A., & Ploegh, H. L. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.9.3132 · Cited by 319 · cited 1×
“Primers used were 5 -AAAAGGCCAAGGAGCACAAC-3 and 5 -TTGAGGAGGGGCCGAGTTC-3 for the FKBP51 PCR (TIB-Molbiol, Berlin, Germany) and 5 -CCAGCAGAGAATGGAAAGTC-3 and 5 -GATGCTGCTTACATGTCTCG-3 for the 2-microglobulin ( 2m) PCR (20).”
MethodHuizenga, N. A. T. M. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.1.144 · Cited by 265 · cited 1×
“polymorphisms of the GC receptor (10, 11) and the avail-”
BackgroundSyndromes of Glucocorticoid Resistance
Chrousos, G. P., Detera-Wadleigh, S. D., & Karl, M. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-11-199312010-00009 · Cited by 235 · cited 1×
“Partial insensitivity to glucocorticoids can be caused by several mechanisms and has been described in many other patients (42).”
BackgroundNair, S. C., Rimerman, R. A., Toran, E. J., Chen, S., Prapapanich, V., Butts, R. N., & Smith, D. F. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.2.594 · Cited by 196 · cited 1×
“The immunophilin FKBP51 forms part of the Hsp90 steroid receptor complex (38) and has been shown to reduce the affinity of both the squirrel monkey and human GC receptor for its ligand when overexpressed (39, 40).”
Background
Cited by
Items 101–200 of 293
Fujii, T., Hori, H., Ota, M., Hattori, K., Teraishi, T., Sasayama, D., Yamamoto, N., Higuchi, T., & Kunugi, H. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.01.007 · Cited by 53
Nagy, C., Vaillancourt, K., & Turecki, G. (2018) · Genes, Brain and Behavior · doi:10.1111/gbb.12446 · Cited by 44
“that maintains GR signaling within an appropriate range in normal conditions.(35,36)”
BackgroundCannabinoids as therapeutics for PTSD
Sbarski, B., & Akirav, I. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107551 · Cited by 50
A severe mouse model of spinal muscular atrophy develops early systemic inflammation
Wan, B., Feng, P., Guan, Z., Sheng, L., Liu, Z., & Hua, Y. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy300 · Cited by 53
Tetrabromobisphenol-A Promotes Early Adipogenesis and Lipogenesis in 3T3-L1 Cells
Chappell, V. A., Janesick, A., Blumberg, B., & Fenton, S. E. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfy209 · Cited by 48
“where FKBP5 then binds and regulates GR sensitivity to further stimulation by ligands (Vermeer et al., 2003).”
BackgroundHerok, R., Konopacka, M., Polańska, J., Świerniak, A., Rogoliński, J., Jaksik, R., Hancock, R., & Rzeszowska‐Wolny, J. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.11.033 · Cited by 46
FKBP5 mRNA Expression Is a Biomarker for GR Antagonism
Bali, U., Phillips, T., Hunt, H., & Unitt, J. F. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1624 · Cited by 50
Gawlik, M., Moller-Ehrlich, K., Mende, M., Jovnerovski, M., Jung, S., Jabs, B., Knapp, M., & Stoeber, G. (2006) · BMC Psychiatry · doi:10.1186/1471-244x-6-52 · Cited by 43
“Functionally, cortisol induces the FKBP5 expression by glucocorticoid-response-elements in human lymphocytes [4].”
BackgroundLawford‐Smith, H. (2015) · Journal of Social Ontology · doi:10.1515/jso-2015-0008 · Cited by 60
Brett, Z. H., Humphreys, K. L., Fleming, A. S., Kraemer, G. W., & Drury, S. S. (2015) · Development and Psychopathology · doi:10.1017/s0954579415000036 · Cited by 44
Rees‐Unwin, K. S., Craven, R. A., Davenport, E. L., Hanrahan, S. J., Totty, N. F., Dring, A. M., Banks, R. E., Morgan, G. J., & Davies, F. E. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06837.x · Cited by 50
“In endocrine diseases one mechanism explaining drug resistance is the constitutive upregulation of FKBP5 reducing the affinity of the GR for its ligand (Reynolds et al, 1999; Denny et al, 2000; Vermeer et al, 2003).”
BackgroundStamm, T. J., Rampp, C., Wiethoff, K., Stingl, J., Mößner, R., O′Malley, G., Ricken, R., Seemüller, F., Keck, M. E., Fisher, R., et al. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115620459 · Cited by 44
“Elevated levels of FKBP5 lead to a decreased GR sensitivity resulting in decreased feedback sensitivity of the system (Vermeer et al., 2003).”
BackgroundCharting the perfect storm: emerging biological interfaces between stress and stroke
Kronenberg, G., Schöner, J., Nolte, C. H., Heinz, A., Endres, M., & Gertz, K. R. (2017) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-017-0794-x · Cited by 47
“As activation of the GR leads to increased FKBP5 transcription, this creates an ultra-fast negative feedback loop [35].”
BackgroundKino, T., Souvatzoglou, E., Charmandari, E., Ichijo, T., Driggers, P., Mayers, C., Alatsatianos, A., Manoli, I., Westphal, H., Chrousos, G. P., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m509339200 · Cited by 42
Yeo, S., Enoch, M. ‐., Gorodetsky, E., Akhtar, L., Schuebel, K., Roy, A., & Goldman, D. (2017) · Genes, Brain and Behavior · doi:10.1111/gbb.12342 · Cited by 35
“After rapid induction of FKBP5 in response to GR activation, FKBP5 binds to the GR, reduces the affinity of GR for cortisol and decreases translocation of the GR to the nucleus (Vermeer et al. 2003; Zannas & Binder 2014).”
BackgroundInteractions between FKBP5 variation and environmental stressors in adolescent Major Depression
Piechaczek, C., Greimel, E., Feldmann, L., Pehl, V., Allgaier, A., Frey, M., Freisleder, F. J., Halldorsdottir, T., Binder, E. B., Ising, M., et al. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.03.025 · Cited by 41
The Pathways between Cortisol-Related Regulation Genes and PTSD Psychotherapy
Castro-Vale, I., & Carvalho, D. M. (2020) · Healthcare · doi:10.3390/healthcare8040376 · Cited by 46
“FKBP5 overexpression is associated ith resistance [68,69].”
BackgroundVermeer, H., Hendriks-Stegeman, B. I., van Suylekom, D., Rijkers, G. T., van Buul-Offers, S. C., & Jansen, M. (2004) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.12.011 · Cited by 45
Self-citationProgress and prospects in pharmacogenetics of antidepressant drugs
Fabbri, C., Crisafulli, C., Calabrò, M., Spina, E., & Serretti, A. (2016) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2016.1202237 · Cited by 37
“role in stress response and hypothalamic–pituitary–adrenal (HPA) activity [20].”
BackgroundLahti, J., Ala-Mikkula, H., Kajantie, E., Haljas, K., Eriksson, J. G., & Räikkönen, K. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.10.022 · Cited by 37
“These FKBP5 functions of inhibition and induction create an intracellular, ultrashort feedback loop that regulates glucocorticoid receptor sensitivity (15).”
BackgroundThe gut microbiota affects corticosterone production in the murine small intestine
Ergang, P., Vagnerová, K., Hermanová, P., Vodička, M., Jágr, M., Šrůtková, D., Dvořáček, V., Hudcovic, T., & Pácha, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084229 · Cited by 37
“This finding is in agreement with stronger upregulation of intestinal Cyp11a1 and Stard3, encoding a rate-limiting enzyme in steroid synthesis and a mitochondrial cholesterol importer [45], respectively, and Fkbp5, a sensitive marker of glucocorticoid exposure [35], in SPF than GF mice.”
BackgroundResultCellular pharmacodynamics of immunosuppressive drugs for individualized medicine
Hirano, T. (2006) · International Immunopharmacology · doi:10.1016/j.intimp.2006.09.020 · Cited by 41
Interaction and Functional Interference of Glucocorticoid Receptor and SOCS1
Haffner, M. C., Jurgeit, A., Berlato, C., Geley, S., Parajuli, N., Yoshimura, A., & Doppler, W. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801041200 · Cited by 35
Functions of the Hsp90-Binding FKBP Immunophilins
Guy, N. C., Garcia, Y. A., Sivils, J. C., Galigniana, M. D., & Cox, M. B. (2015) · Subcellular Biochemistry · doi:10.1007/978-3-319-11731-7_2 · Cited by 35
“In addition to the aforementioned structural differences between FKBP51 and FKBP52, another distinction is that the FKBP51 gene is highly inducible by glucocorticoids, androgens, and progesterone (Baughman et al. 1995; Kester et al. 1997; Zhu et al. 2001; Yoshida et al. 2002; Vermeer et al. 2003; Hubler et al. 2003; F…”
BackgroundGreen, M. R., Nottrodt, R. E., Simone, J. J., & McCormick, C. M. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.07.210 · Cited by 39
Ferrer, A., Costas, J., Labad, J., Salvat-Pujol, N., Segalàs, C., Urretavizcaya, M., Real, E., de Arriba-Arnau, A., Alonso, P., Crespo, J. M., et al. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.08.003 · Cited by 35
Molecular mechanisms underlying mifepristone's agonistic action on ovarian cancer progression
Ponikwicka‐Tyszko, D., Chruściel, M., Stelmaszewska, J., Bernaczyk, P., Chrusciel, P., Sztachelska, M., Scheinin, M., Bidziński, M., Szamatowicz, J., Huhtaniemi, I. T., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.08.035 · Cited by 34
Role of adrenoceptor-linked signaling pathways in the regulation of CYP1A1 gene expression
Konstandi, M., Kostakis, D., Harkitis, P., Μαρσέλος, Μ., Johnson, E. O., Adamidis, K. N., & Lang, M. A. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.09.024 · Cited by 35
Association between FKBP5 Functional Polymorphisms and Completed Suicide
Fudalej, S., Kopera, M., Wołyńczyk-Gmaj, D., Fudalej, M., Krajewski, P., Wasilewska, K., Szymański, K., Chojnicka, I., Podgórska, A., Wojnar, M., et al. (2015) · Neuropsychobiology · doi:10.1159/000441659 · Cited by 35
Breen, M. S., Bierer, L. M., Daskalakis, N. P., Bader, H. N., Makotkine, I., Chattopadhyay, M., Xu, C., Grice, A. B., Tocheva, A. S., Flory, J. D., et al. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0539-x · Cited by 34
Qiu, B., Luczak, S. E., Wall, T. L., Kirchhoff, A. M., Xu, Y., Eng, M. Y., Stewart, R. B., Shou, W., Boehm, S. L., Chester, J. A., et al. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17081271 · Cited by 32
“In addition, glucocorticoid treatment increased Fkbp5 expression in peripheral tissue [31] and the brain [32].”
BackgroundFries, G. R., Quevedo, J., Zeni, C., Kazimi, I. F., Zunta‐Soares, G. B., Spiker, D. E., Bowden, C. L., Walss‐Bass, C., & Soares, J. C. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.32 · Cited by 34
Bhadri, V. A., Cowley, M. J., Kaplan, W. H., Trahair, T. N., & Lock, R. B. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-565 · Cited by 35
“ILMN_5080450 ZBTB16 83.77 < 2.2E-16 < 2.2E-16 zinc finger and BTB domain containing 16 ILMN_3800088 MMP7 53.22 < 2.2E-16 < 2.2E-16 matrix metallopeptidase 7 ILMN_1770593 CH25H 53.14 < 2.2E-16 < 2.2E-16 cholesterol 25-hydroxylase ILMN_6560328 C6orf85 44.60 < 2.2E-16 < 2.2E-16 chromosome 6 open reading frame 85 ILMN_757…”
BackgroundInfluentialREDD1/DDIT4-Independent mTORC1 Inhibition and Apoptosis by Glucocorticoids in Thymocytes
Wolff, N. C., McKay, R. M., & Brugarolas, J. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0625 · Cited by 33
“Expression of the canonical glucocorticoid-response gene Fkbp5 (37) was blocked by actinomycin D (Fig.”
Binder, E. B. (2017) · European Journal of Psychotraumatology · doi:10.1080/20008198.2017.1412745 · Cited by 29
Agrawal, S., Guess, A. J., Benndorf, R., & Smoyer, W. E. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.071654 · Cited by 31
“Given our observations that TZDs are able to both protect podocytes and stimulate the GR, although to a lesser extent than Dex, we examined the ability of Rosi and Pio to regulate the transcription of two well studied GC-responsive genes, FKBP51 and GILZ (Vermeer et al., 2003; Ayroldi and Riccardi, 2009).”
BackgroundInfluentialOnda, K., Nagashima, M., Kawakubo, Y., Inoue, S., Hirano, T., & Oka, K. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.032 · Cited by 28
Chun, E., Lee, H. S., Bang, B., Kim, T., Lee, S.-H., Kim, J. H., Cho, S., Min, K., Kim, Y. Y., & Park, H. (2010) · Journal of Clinical Immunology · doi:10.1007/s10875-010-9463-9 · Cited by 28
“The use of a larger dose of inhaled CSs in severe asthmatics was a possible reason for this, as it is known that FKBP51 expression is also induced by CSs themselves [11, 12].”
BackgroundPlexinB1 Promotes Nuclear Translocation of the Glucocorticoid Receptor
Williamson, M. P., Garg, R., & Wells, C. M. (2019) · Cells · doi:10.3390/cells9010003 · Cited by 28
Kang, C., Shi, J., Gong, Y., Wei, J., Zhang, M., Ding, H., Wang, K., Yu, Y., Wang, S., & Han, J. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.01.051 · Cited by 28
Lin, C.-C., Cheng, P., Hsiao, M., & Liu, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105494 · Cited by 29
“Studies have revealed that a higher FKBP5 performance yields lower GR sensitivity [56,57].”
BackgroundEpigenetics in Posttraumatic Stress Disorder
Rampp, C., Binder, E. B., & Provençal, N. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-800977-2.00002-4 · Cited by 28
Lukić, I., Mitić, M., Soldatović, I., Jovicic, M. J., Marić, N. P., Radulović, J., & Adžić, M. (2014) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0451-z · Cited by 28
“Furthermore, FKBP5 expression is induced by glucocorticoids, as a part of an intracellular ultra-short negative feedback loop restraining GR activity (Binder 2009; Vermeer et al. 2003).”
BackgroundPark, J., Kim, M., Na, G., Jeon, I., Kwon, Y.-K., Kim, J.-H., Youn, H., & Koo, Y. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.08.002 · Cited by 26
Costello, H. M., Krilis, G., Grenier, C., Severs, D., Czopek, A., Ivy, J. R., Nixon, M., Holmes, M. C., Livingstone, D. E. W., Hoorn, E. J., et al. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac160 · Cited by 27
“Glucocorticoid exposure, reported by mRNA encoding FK506-binding protein 5 ( Fkbp5) 27 was increased in the hippocampus and anterior pituitary but not in the hypothalamus, where mRNA abundance for the glucocorticoid receptor ( Nr3c1 ) was significantly reduced ( Figure 4 ).”
InfluentialMiller, A. L., Komak, S., Webb, M. S., Leiter, E. H., & Thompson, E. B. (2007) · Cancer Cell International · doi:10.1186/1475-2867-7-18 · Cited by 26
“Several reports have suggested the use of the inductive response of the immunophilin FKBP5 (also known as FKBP51) as a diagnostic tool for GC response in peripheral blood mononuclear, T- and B-lymphocytes, and the highly Dex-resistant lymphoblastoid cell line IM-9 [ 42- 44 ].”
BackgroundWeissenrieder, J., Reilly, J. E., Neighbors, J. D., & Hohl, R. J. (2018) · The Prostate · doi:10.1002/pros.23707 · Cited by 24
Novel roles of FKBP5 in muscle alteration induced by gravity change in mice
Shimoide, T., Kawao, N., Tamura, Y., Morita, H., & Kaji, H. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.09.126 · Cited by 25
Distinct pulmonary and systemic effects of dexamethasone in severe COVID-19
Neyton, L. P. A., Patel, R. K., Sarma, A. A., Ansel, K. M., Christenson, S. A., Adkisson, M., Eckalbar, W. L., Maliskova, L., Schroeder, A., Bueno, R., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49756-2 · Cited by 24
“058forCD4 and CD8 T cells, respectively), which is a canonical transcriptomic marker of glucocorticoid receptor activity 18 .”
Immunohistochemical analysis of FKBP51 in human cancers
Staibano, S., Mascolo, M., Ilardi, G., Siano, M., & Rosa, G. D. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.04.001 · Cited by 23
Iudicibus, S. D., Lucafò, M., Vitulo, N., Martelossi, S., Zimbello, R., Pascale, F. D., Forcato, C., Naviglio, S., Silvestre, A. D., Gerdol, M., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051399 · Cited by 22
“Moreover, GR sensitivity is additionally regulated by GCs through the induction of FKBP5 expression, thereby establishing an intracellular ultra-short negative feedback loop [25], which might sustain the upregulation that was observed in our analysis.”
BackgroundBain, C., Draxler, D. F., Taylor, R., Wallace, S. K. A., Gouldthorpe, O., Corcoran, T. B., Myles, P. S., Medcalf, R. L., & Bozaoglu, K. (2018) · Anaesthesia · doi:10.1111/anae.14306 · Cited by 22
“• GR cochaperone modulates GR/GC signalling [30] • Classic immediate GR/GC target • Reliable marker of GR activation [7] CD-1D Antigen-presenting glycoprotein • Anti-inflammatory • May be susceptible to TA [21] • Stimulates inhibitory NK and invariant T cells [31] HLA-DR Human histocompatibility leucocyte antigen-DR •…”
BackgroundNo association between FKBP5 gene methylation and acute and long-term cortisol output
Alexander, N., Kirschbaum, C., Stalder, T., Muehlhan, M., & Vogel, S. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0846-2 · Cited by 18
Proteomic analysis of the cortisol‐mediated stress response in THP‐1 monocytes using DIGE technology
Billing, A. M., Fack, F., Renaut, J., Olinger, C. M., Schote, A. B., Turner, J. D., & Muller, C. P. (2007) · Journal of Mass Spectrometry · doi:10.1002/jms.1270 · Cited by 21
Brazeau, D. A. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03231-3 · Cited by 24
Löbel, M., Mooslechner, A. A., Bauer, S., Günther, S., Letsch, A., Hanitsch, L. G., Grabowski, P., Meisel, C., Volk, H., & Scheibenbogen, C. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0628-4 · Cited by 22
Bancos, I., Hatipoğlu, B., Yuen, K. C. J., Chandramohan, L., Chaudhari, S., & Moraitis, A. G. (2021) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2021.100256 · Cited by 24
“previous studies, in which FKBP5 levels increased in response to glucocorticoid administration in vitro, ex vivo, as well as in rodents and healthy volunteers [11,18,21].”
BackgroundHolownia, A., Mroz, R. M., Kolodziejczyk, A., Chyczewska, E., & Braszko, J. J. (2009) · European journal of medical research · doi:10.1186/2047-783x-14-s4-108 · Cited by 20
“Interestingly, steroid hormones themselves regulate immunophilin levels and may increase systemic FKBP51 expression, producing partial functional feedback inhibition of GR [24, 25].”
BackgroundBoe, D. M., Hulsebus, H. J., Najarro, K. M., Mullen, J. E., Kim, H., Tan, A. C., McMahan, R. H., & Kovacs, E. J. (2022) · Journal of Leukocyte Biology · doi:10.1002/jlb.3hi0620-399rr · Cited by 20
García-Gómara, M., Legarra-Marcos, N., Serena, M., Rojas-de-Miguel, E., Espelosin, M., Marcilla, I., Pérez‐Mediavilla, A., Luquín, M. R., Lanciego, J. L., Burrell, M. A., et al. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.01.049 · Cited by 21
Vassiliou, A. G., Stamogiannos, G., Jahaj, E., Botoula, E., Floros, G., Vassiliadi, D. A., Ilias, Ι., Tsagarakis, S., Tzanela, M., Orfanos, S. E., et al. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.110656 · Cited by 22
Hsp90-Binding Immunophilins As A Potential New Platform for Drug Treatment
Erlejman, A. G., Lagadari, M., & Galigniana, M. D. (2013) · Future Medicinal Chemistry · doi:10.4155/fmc.13.7 · Cited by 24
Panagiotou, C., Lambadiari, V., Maratou, E., Geromeriati, C., Artemiadis, A., Dimitriadis, G., & Moutsatsou, P. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01260-2 · Cited by 20
A comparison of in vitro bioassays to determine cellular glucocorticoid sensitivity
Vermeer, H., Hendriks-Stegeman, B. I., Stuart, A. V., van Buul-Offers, S. C., & Jansen, M. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1500041 · Cited by 20
Self-citationBilling, A. M., Revets, D., Hoffmann, C., Turner, J. D., Vernocchi, S., & Muller, C. P. (2012) · Journal of Proteomics · doi:10.1016/j.jprot.2012.01.008 · Cited by 18
Bahde, R., Kapoor, S., Bhargava, K. K., Schilsky, M. L., Palestro, C. J., & Gupta, S. K. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.092361 · Cited by 17
“Evidence has confirmed this process: 64Cu was excreted in LEA and LEC1/2 rats and not at all in LEC rats, in which Atp7b deficiency was the only known defect; acute or chronic liver injury did not alter 64Cu excretion; increase in bile flow alone, that is, after sodium valproate (21), did not alter 64Cu excretion; lac…”
ResultHampel, M., Blasco, J., Babbucci, M., Ferraresso, S., Bargelloni, L., & Milan, M. (2017) · Marine Environmental Research · doi:10.1016/j.marenvres.2017.04.012 · Cited by 18
Terock, J., der Auwera, S. V., Hannemann, A., Janowitz, D., Homuth, G., Teumer, A., & Grabe, H. J. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.06.008 · Cited by 17
Endocrinology of the Stress Response During Critical Illness
Marik, P. E. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-44942-7.00076-5 · Cited by 21
Interferon‐inducible factor 16 is a novel modulator of glucocorticoid action
Berry, A. A., Matthews, L. C., Jangani, M., Plumb, J., Farrow, S. N., Buchan, N. S., Wilson, P. A., Singh, D., Ray, D. W., & Donn, R. P. (2010) · The FASEB Journal · doi:10.1096/fj.09-139998 · Cited by 21
“FKBP5, MT1X, GLUL, and GILZ were upregulated and ASPH, IL6ST, and MY01B were downregulated in response to treatment with Dex, which is in accordance with previous findings (7, 26, 27) (Fig.”
ResultZhang, S., Cheon, M., Park, H.-Y., Kim, T., & Chung, C. (2021) · Neuroscience · doi:10.1016/j.neuroscience.2021.12.020 · Cited by 16
Biomarker panel increases accuracy for identification of an MS relapse beyond sNfL
Gawde, S., Agasing, A. M., Bhatt, N., Toliver, M., Kumar, G., Massey, K., Nguyen, A., Mao‐Draayer, Y., Macwana, S., DeJager, W., et al. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.103922 · Cited by 19
Induction of FKBP51 by aldosterone in intestinal epithelium
Petrovich, E., Asher, C., & Garty, H. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.10.006 · Cited by 18
Proteomic Analysis in Multiple Myeloma Research
Čumová, J., Potáčová, A., Zdráhal, Z., & Hájek, R. (2010) · Molecular Biotechnology · doi:10.1007/s12033-010-9326-x · Cited by 17
“These studies and studies in other disease models have suggested that laboratory measurements of FKBP5 may be useful as a screening test to predict the clinical response to dexamethasone therapy [ 72 ].”
ResultEscoll, P., Ranz, I., Muñoz-Antón, N., Rym, A. M. V. D., Álvarez‐Mon, M., Martínez-Alonso, C., Sanz, E., & de-la-Hera, A. (2015) · Mediators of Inflammation · doi:10.1155/2015/347965 · Cited by 18
“The rationale for the selected DEX dose (10M = 10 nM) was to use the same dose that has been uniformly reported in studies of several GR signaling pathway mechanisms and allows for crosscomparison of our results [30, 32, 35, 37, 40, 61].”
BackgroundMethodInfluentialMining Microarrays for Metabolic Meaning: Nutritional Regulation of Hypothalamic Gene Expression
Mobbs, C. V., Yen, K., Mastaitis, J. W., Nguyen, H., Watson, E., Wurmbach, E., Sealfon, S. C., Brooks, A. I., & Salton, S. R. (2004) · Neurochemical Research · doi:10.1023/b:nere.0000023596.49140.e0 · Cited by 17
Iversen, M., Mulugeta, T. D., Blikeng, B. G., West, A. C., Jørgensen, E. H., Sandven, S. R., & Hazlerigg, D. G. (2020) · PLoS ONE · doi:10.1371/journal.pone.0227496 · Cited by 17
Association of Eosinophilic Inflammation with FKBP51 Expression in Sputum Cells in Asthma
Tajiri, T., Matsumoto, H., Niimi, A., Ito, I., Oguma, T., Nakaji, H., Inoue, H., Iwata, T., Nagasaki, T., Kanemitsu, Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065284 · Cited by 15
“In previous studies using cultured squirrel monkey lymphocytes and human lymphocytes, FKBP51 mRNA was induced by GC [24], and its overexpression was thought to inhibit GRa signaling by reducing the binding affinity of GC to GRa [22,25], impairing nuclear translocation of GRa [26] and promoting nuclear translocation of…”
BackgroundZheng, H., Zhang, H., Chen, S., Li, M., Fu, T., & Yang, Z. (2020) · The FASEB Journal · doi:10.1096/fj.201902911rr · Cited by 15
Modulation of the Glucocorticoid Receptor Activity by Post-Translational Modifications
Liberman, A. C., Antunica-Noguerol, M., & ARZT, E. S. (2014) · Nuclear Receptor Research · doi:10.11131/2014/101086 · Cited by 18
Corticosteroid therapy in acute respiratory distress syndrome
Lamontagne, F., Brower, R. G., & Meade, M. O. (2012) · Canadian Medical Association Journal · doi:10.1503/cmaj.120582 · Cited by 16
Potential role of FKBP5 single‐nucleotide polymorphisms in functional seizures
Asadi‐Pooya, A. A., Simani, L., Asadollahi, M., Rashidi, F. S., Ahmadipour, E., Alavi, A., Roozbeh, M., Akbari, N., & Firouzabadi, N. (2023) · Epilepsia Open · doi:10.1002/epi4.12716 · Cited by 16
Luchak, A., Solomon, L. A., Kanagalingam, T., Vijeyakumaran, M., Rowe, B. H., & Cameron, L. (2020) · BMC Immunology · doi:10.1186/s12865-020-00383-8 · Cited by 15
Brotto, M. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.052670 · Cited by 16
A novel specific bioassay for the determination of glucocorticoid bioavailability in human serum
Vermeer, H., Hendriks-Stegeman, B. I., van den Brink, C. E., van der Saag, P. T., van der Burg, B., van Buul-Offers, S. C., & Jansen, M. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01793.x · Cited by 15
“…following FP inhalation is likely to be caused foremost by the lung-absorbed fraction, as FP absorbed in the gastrointestinal tract is almost 54 H. Vermeer et al. © 2003 Blackwell Publishing Ltd, Clinical Endocrinology, 59, 49–55 completely inactivated during the hepatic first pass (Dempsey et…”
BackgroundSelf-citationPrednisolone-Induced Changes in Gene-Expression Profiles in Healthy Volunteers
Toonen, E. J. M., Fleuren, W., Nässander, U. K., van Lierop, M.-J. C., Bauerschmidt, S., Dokter, W. H. A., & Alkema, W. B. L. (2011) · Pharmacogenomics · doi:10.2217/pgs.11.34 · Cited by 15
Mifepristone Treatment Promotes Testicular Leydig Cell Tumor Progression in Transgenic Mice
Ponikwicka‐Tyszko, D., Chruściel, M., Puławska, K., Bernaczyk, P., Sztachelska, M., Guo, P., Li, X., Toppari, J., Huhtaniemi, I. T., Wołczyński, S., et al. (2020) · Cancers · doi:10.3390/cancers12113263 · Cited by 13
Ryu, H., Cheon, M., & Chung, C. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.12.020 · Cited by 13
Fukushima, H., Hirano, T., & Oka, K. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.05.021 · Cited by 13
Liu, Y., Lian, J., Fu, Y., Wang, S., Liu, Y., Zhang, R., & Han, H. (2025) · Neurobiology of Stress · doi:10.1016/j.ynstr.2025.100762 · Cited by 13
“FKBP51 localizes to both the cytoplasm and nucleus, where it dynamically assembles with heat shock protein 90 (Hsp90) into a chaperone complex that allosterically regulates the glucocorticoid receptor (GR) (Noddings et al., 2023; Verkhivker, 2022; Vermeer et al., 2003).”
The Effect of Nicotine on HPA Axis Activity in Females is Modulated by the FKBP5 Genotype
Koopmann, A., Bez, J., Leménager, T., Hermann, D., Dinter, C., Reinhard, I., Schuster, R., Wiedemann, K., Winterer, G., & Kiefer, F. (2016) · Annals of Human Genetics · doi:10.1111/ahg.12153 · Cited by 14
“Furthermore, activation of the glucocorticoid response elements by cortisol triggers FKBP5 expression (Vermeer et al., 2003).”
BackgroundGenomic and non-genomic effects of glucocorticoids
Тодосенко, Н. М., Koroleva, Y. A., Хазиахматова, О. Г., Yurova, K. A., & Litvinova, L. S. (2017) · Genes and Cells · doi:10.23868/201703003 · Cited by 13
Cellular and cytoskeletal alterations of scleral fibroblasts in response to glucocorticoid steroids
Bogarin, T., Saraswathy, S., Akiyama, G., Xie, X., Weinreb, R. N., Zheng, J., & Huang, A. S. (2019) · Experimental Eye Research · doi:10.1016/j.exer.2019.107774 · Cited by 12
Hernández‐Díaz, Y., González‐Castro, T. B., Tovilla‐Zárate, C. A., Juárez‐Rojop, I. E., López‐Narváez, M. L., Pérez‐Hernández, N., Rodríguez-Pérez, J. M., & Mendoza, A. D. G. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.11.002 · Cited by 13
Effects of pre- and post-natal exposure to bisphenol A on the stress system
Kitraki, E., Nalvarte, I., Alavian‐Ghavanini, A., & Rüegg, J. (2016) · Endocrine Disruptors · doi:10.1080/23273747.2016.1184775 · Cited by 14
Adipogenesis is under surveillance of Hsp90 and the high molecular weight Immunophilin FKBP51
Toneatto, J., Charó, N. L., Galigniana, N. M., & Piwien‐Pilipuk, G. (2015) · Adipocyte · doi:10.1080/21623945.2015.1049401 · Cited by 12
Richards, R. C., Achenbach, J. C., Short, C. E., Kimball, J., Reith, M., Driedzic, W. R., & Ewart, K. V. (2008) · Gene · doi:10.1016/j.gene.2008.08.002 · Cited by 11
“Furthermore, FK506bp51 has been identified as a convenient marker for glucocorticoid sensitivity in humans for adjustment of dosages in patients (Vermeer et al., 2003) as a result of its predictable and measurable response to cortisol.”
BackgroundKeijser, R., Olofsdotter, S., Nilsson, K. W., & Åslund, C. (2021) · Journal of Neural Transmission · doi:10.1007/s00702-021-02405-0 · Cited by 13
Marcolongo, F., Scarlata, S., Tomino, C., Dominicis, C. D., Giacconi, R., Malavolta, M., Bonassi, S., Russo, P., & Prinzi, G. (2022) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000308 · Cited by 11
“FKBP5 is responsive to stress exposure and elevated glucocorticoid levels, which affect its subsequent transcription (Vermeer et al., 2003; Zhang et al., 2008; Lekman et al., 2008; Zimmermann et al., 2011; Zannas and Binder, 2014).”
BackgroundRole of FK506 binding protein 5 (FKBP5) in osteoclast differentiation
Kimura, M., Nagai, T., Matsushita, R., Hashimoto, A., Miyashita, T., & Hirohata, S. (2012) · Modern Rheumatology · doi:10.1007/s10165-012-0809-4 · Cited by 11
Metadata
- Authors
- Vermeer, H., Hendriks-Stegeman, B. I., van der Burg, B., van Buul-Offers, S. C., & Jansen, M.
- Affiliations
- University Medical Center Utrecht (NL)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2003-01
- Volume
- 88
- Issue
- 1
- Pages
- 277-284
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2087836842
- Cited by
- 285
- References
- 40
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 5 · 2023: 9 · 2022: 12 · 2021: 11 · 2020: 18 · 2019: 19 · 2018: 12 · 2017: 15 · 2016: 18 · 2015: 18 · 2014: 15 · 2013: 11 · 2012: 17
- FWCI
- 4.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- glucocorticoids, FKBP51, FKBP, glucocorticoid receptor, gene transcription, lymphocytes, peripheral blood mononuclear cells, glucocorticoid sensitivity, glucocorticoid potency, dexamethasone, congenital adrenal hyperplasia, 21-hydroxylase deficiency, cycloheximide
- MeSH terms
- Tacrolimus Binding Protein 5, Biological Availability, Computer Systems, Dexamethasone, Drug Resistance, Female, Glucocorticoids, Humans, Infant, Lymphocytes, Receptors, Glucocorticoid, RNA, Messenger, Time Factors, Tumor Cells, Cultured, Blotting, Northern, Biomarkers, Polymerase Chain Reaction, Tacrolimus Binding Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.